Extracellular haemoglobin upregulates and binds to tissue factor on macrophages: Implications for coagulation and oxidative stress

Summary

The mechanisms of crosstalk between haemolysis, coagulation and innate immunity are evolutionarily conserved from the invertebrate haemocyanin to the vertebrate haemoglobin (Hb). In vertebrates, extracellular Hb resulting from haemolytic infections binds bacterial lipopolysaccharide (LPS) to unleash the antimicrobial redox activity of Hb. Because bacterial invasion also upregulates tissue factor (TF), the vertebrate coagulation initiator, we asked whether there may be functional interplay between the redox activity of Hb and the procoagulant activity of TF. Using real-time PCR, TF-specific ELISA, flow cytometry and TF activity assay, we found that Hb upregulated the expression of functional TF in macrophages. ELISA, flow cytometry and immunofluorescence microscopy showed binding between Hb and TF, in isolation and in situ. Bioinformatic analysis of Hb and TF protein sequences showed co-evolution across species, suggesting that Hbβ binds TF. Empirically, TF suppressed the LPS-induced activation of Hb redox activity. Furthermore, Hb desensitised TF to the effects of antioxidants like glutathione or serum. This bi-directional regulation between Hb and TF constitutes a novel link between coagulation and innate immunity. In addition, induction of TF by Hb is a potentially central mechanism for haemolysis to trigger coagulation.

Keywords

Haemolysis - lipopolysaccharide - sepsis - oxidative stress - co-evolution of haemoglobin and tissue factor

^* Co-senior authors.

• References

• 1 Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately?. Blood 2009; 114: 2367-2374.
• 2 Opal SM, Esmon CT. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care 2003; 7: 23-38.
• 3 Muta T, Iwanaga S. The role of haemolymph coagulation in innate immunity. Curr Opin Immunol 1996; 8: 41-47.
• 4 Decker H. et al. SDS-induced phenoloxidase activity of haemocyanins from Li-mulus polyphemus, Eurypelma californicum, and Cancer magister. J Biol Chem 2001; 276: 17796-17799.
• 5 Jiang N. et al. Respiratory protein-generated reactive oxygen species as an antimicrobial strategy. Nat Immunol 2007; 8: 1114-1122.
• 6 Giulivi C, Davies KJ. A novel antioxidant role for haemoglobin. The compropor-tionation of ferrylhaemoglobin with oxyhaemoglobin. J Biol Chem 1990; 265: 19453-19460.
• 7 De SN, Sengupta KP, Chanda NN. Intravascular haemolysis in cholera; the effect of oxytetracycline. Lancet 1954; 266: 807-809.
• 8 Sengers RC. Murine malaria. 3. Protein concentrations during Plasmodium ber-ghei infection. Exp Parasitol 1971; 30: 22-29.
• 9 Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 1996; 42: 1589-1600.
• 10 Alayash AL. Haemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?. Nat Biotechnol 1999; 17: 545-549.
• 11 Du R, Ho B, Ding JL. Rapid reprogramming of haemoglobin structure-function exposes multiple dual-antimicrobial potencies. EMBO J 2010; 29: 632-642.
• 12 White CT. et al. Synergistic toxicity of endotoxin and haemoglobin. J Lab Clin Med 1986; 108: 132-137.
• 13 Roth RI. Haemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 1994; 83: 2860-2865.
• 14 Nemerson Y. Tissue factor and haemostasis. Blood 1988; 71: 1-8.
• 15 Banner DW. et al. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380: 41-46.
• 16 Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of haemostasis and thrombosis. Am J Pathol 1989; 134: 1087-1097.
• 17 Herbert JM. et al. IL-4 inhibits LPS-, IL-1 beta- and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes. FEBS Lett 1992; 310: 31-33.
• 18 Cunningham MA. et al. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 1999; 94: 3413-3420.
• 19 Senden NH. et al. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol 1998; 161: 4318-4324.
• 20 Taylor Jr. FB. et al. Lethal E, coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127-134.
• 21 Ataga KI. Hypercoagulability and thrombotic complications in haemolytic anemias. Haematologica 2009; 94: 1481-1484.
• 22 Setty BN. et al. Heme induces endothelial tissue factor expression: potential role in haemostatic activation in patients with haemolytic anemia. J Thromb Hae-most 2008; 6: 2202-2209.
• 23 Weed RI, Reed CF, Berg G. Is haemoglobin an essential structural component of human erythrocyte membranes?. J Clin Invest 1963; 42: 581-588.
• 24 Nagai T, Kawabata S. A link between blood coagulation and prophenol oxidase activation in arthropod host defense. J Biol Chem 2000; 275: 29264-29267.
• 25 Chantrathammachart P. et al. Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease. Blood 2012; 120: 636-646.
• 26 Drake TA. et al. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142: 1458-1470.
• 27 Ekser B. et al. Potential factors influencing the development of thrombocytope-nia and consumptive coagulopathy after genetically modified pig liver xeno-transplantation. Transpl Int 2012; 25: 882-896.
• 28 Tsuchiya S. et al. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982; 42: 1530-1536.
• 29 Auwerx J. The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 1991; 47: 22-31.
• 30 Gershoni M. et al. Coevolution predicts direct interactions between mtDNA-en-coded and nDNA-encoded subunits of oxidative phosphorylation complex i. J Mol Biol 2010; 404: 158-171.
• 31 Niemetz J, Morrison DC. Lipid A as the biologically active moiety in bacterial endotoxin (LPS)-initiated generation of procoagulant activity by peripheral blood leukocytes. Blood 1977; 49: 947-956.
• 32 Ding JL, Ho B. A new era in pyrogen testing. Trends Biotechnol 2001; 19: 277-281.
• 33 Cooperstock MS. Inactivation of endotoxin by polymyxin B. Antimicrob Agents Chemother 1974; 6: 422-425.
• 34 Drake TA. et al. Functional tissue factor is entirely cell surface expressed on li-popolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 1989; 109: 389-395.
• 35 Du R, Winarsih I, Ho B. et al. Lipid-free apolipoprotein A-1 exerts an antiox-idative role against cell-free haemoglobin. Am J Clin Exp Immunol 2012; 1: 33-48.
• 36 Fabriek BO. et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009; 113: 887-892.
• 37 Jurgens G. et al. Interaction of haemoglobin with enterobacterial lipopolysac-charide and lipid A. Physicochemical characterization and biological activity. Eur J Biochem 2001; 268: 4233-4242.
• 38 Ruf W, Versteeg HH. Tissue factor mutated at the allosteric Cys186-Cys209 dis-ulfide bond is severely impaired in decrypted procoagulant activity. Blood 2010; 116: 500-501 author reply 502-503
• 39 Ahamed J. et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA 2006; 103: 13932-13937.
• 40 Hartmann RC. et al. Paroxysmal nocturnal haemoglobinuria: clinical and laboratory studies relating to iron metabolism and therapy with androgen and iron. Medicine 1966; 45: 331-363.
• 41 Reiter CD. et al. Cell-free haemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8: 1383-1389.
• 42 Ataga KI, Orringer EP. Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 2003; 115: 721-728.
• 43 Liebman HA, Feinstein DI. Thrombosis in patients with paroxysmal noctural haemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor. Thromb Res 2003; 111: 235-238.
• 44 Cadroy Y. et al. Polymorphonuclear leukocytes modulate tissue factor production by mononuclear cells: role of reactive oxygen species. J Immunol 2000; 164: 3822-3828.
• 45 Brisseau GF. et al. Posttranscriptional regulation of macrophage tissue factor expression by antioxidants. Blood 1995; 85: 1025-1035.
• 46 Morrissey JH. et al. Resolution of monomeric and heterodimeric forms of tissue factor, the high-affinity cellular receptor for factor VII. Thromb Res 1988; 50: 481-493.
• 47 Siddiqui FA, Francis JL. Haemoglobin binds melanoma cell tissue factor and enhances its procoagulant activity. Blood Coagul Fibrinolysis 2002; 13: 173-180.
• 48 Dekker JP. et al. A perturbation-based method for calculating explicit likelihood of evolutionary co-variance in multiple sequence alignments. Bioinformatics 2004; 20: 1565-1572.
• 49 Halperin I, Wolfson H, Nussinov R. Correlated mutations: advances and limitations. A study on fusion proteins and on the Cohesin-Dockerin families. Proteins 2006; 63: 832-845.
• 50 Kothari H. et al. Cystine 186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption. Blood 2010; 115: 4273-4283.